We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Moderna’s mRNA Flu Vaccine Candidate Shows Promise as Company Pursues Single Dose Jab to Also Protect Against COVID-19 and RSV
Moderna’s mRNA Flu Vaccine Candidate Shows Promise as Company Pursues Single Dose Jab to Also Protect Against COVID-19 and RSV
Moderna says its messenger RNA flu vaccine candidate, mRNA-1010, successfully boosted titers against all four influenza strains it’s being tested against during an ongoing phase 1 study, even at lowest dose, and that no significant safety concerns were observed.